adjudicada·TD

Daclizumab[Cod Int:262P176|2,0] RISANKIZUMAB 150 MG/ML JPR

1704-1710-AG25·Trato directo·Daclizumab[CodInt:262P176|2,0] RISANKIZUMAB 150 MG